Mackenzie Financial Corp Staar Surgical CO Transaction History

Mackenzie Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$70.55 - $111.58 $9,453 - $14,951	-134 Reduced 4.06%	3,168 $224,000
Q2 2022 Aug 10, 2022	BUY	$50.24 - $80.48 $30,797 - $49,334	613 Added 22.8%	3,302 $234,000
Q1 2022 May 13, 2022	SELL	$57.98 - $93.5 $1,449 - $2,337	-25 Reduced 0.92%	2,689 $215,000
Q4 2021 Feb 14, 2022	SELL	$88.02 - $127.79 $1,760 - $2,555	-20 Reduced 0.73%	2,714 $248,000
Q3 2021 Nov 08, 2021	BUY	$122.75 - $162.68 $138,707 - $183,828	1,130 Added 70.45%	2,734 $351,000
Q2 2021 Aug 11, 2021	BUY	$105.76 - $154.96 $169,639 - $248,555	1,604 New	1,604 $245,000

249

47.4M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.15B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.